Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating costs and expenses
General and administrative	$ 11,683	$ 7,734
Research and development	830	559
Research and development - license acquired	1,833	1,148
Total operating expenses	14,346	9,441
Loss from operations	(14,346)	(9,441)
Other (expenses) income
Other income	64	135
Interest income	687	252
Loss on marketable securities	(5,952)	(1,743)
Change in fair value of investments	(2,560)	3,626
Total other (expenses) income	(7,761)	2,270
Net loss	(22,107)	(7,171)
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	(4,109)
Net Loss Attributable to Common Shareholders	$ (26,216)	$ (7,171)
Net loss per share, basic and diluted
Basic (in Dollars per share)	$ (4.91)	$ (1.48)
Weighted average number of shares outstanding, basic and diluted
Basic (in Shares)	5,334,075	4,846,925